Dori Pelled
Directeur des opérations chez Imel Biotherapeutics, Inc.
Postes actifs de Dori Pelled
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Imel Biotherapeutics, Inc.
 Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Directeur des opérations | 01/03/2019 | - |
Historique de carrière de Dori Pelled
Anciens postes connus de Dori Pelled
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Directeur des opérations | - | 25/06/2018 |
| Corporate Officer/Principal | 25/06/2018 | 01/07/2018 | |
| ENZYMOTEC LTD. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Dori Pelled
| Tel-Aviv University | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistiques
Internationale
| Israël | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Enzymotec Ltd.
 Enzymotec Ltd. BiotechnologyHealth Technology Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. | Health Technology |
Imel Biotherapeutics, Inc.
Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Imel Biotherapeutics, Inc. develops treatment for mitochondrial disease. The company was founded on February 21, 2019 and is headquartered in United States. | Commercial Services |
- Bourse
- Insiders
- Dori Pelled
- Expérience
